Vicente E Torres Selected Research

Fibroblast Growth Factor-23

4/2021	Prognostic Value of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease.
12/2019	Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vicente E Torres Research Topics

Disease

141	Autosomal Dominant Polycystic Kidney (ADPKD) 05/2024 - 08/2000
58	Cysts 05/2024 - 08/2000
45	Polycystic Kidney Diseases (Polycystic Kidney Disease) 05/2024 - 11/2003
28	Disease Progression 10/2023 - 08/2000
20	Polycystic liver disease 01/2020 - 01/2003
15	Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I) 11/2019 - 03/2002
13	Chronic Renal Insufficiency 10/2023 - 05/2008
13	Hypertension (High Blood Pressure) 07/2021 - 08/2003
12	Chronic Kidney Failure (Chronic Renal Failure) 10/2022 - 05/2002
11	Fibrosis (Cirrhosis) 03/2024 - 11/2003
10	Liver Diseases (Liver Disease) 01/2020 - 11/2004
6	Renal Insufficiency (Renal Failure) 10/2023 - 12/2003
6	Inflammation (Inflammations) 01/2022 - 02/2013
5	Pain (Aches) 01/2020 - 06/2010
4	Kidney Diseases (Kidney Disease) 09/2022 - 02/2017
4	Ciliopathies 01/2022 - 09/2009
4	Heart Failure 07/2021 - 05/2013
4	Hypotension (Low Blood Pressure) 05/2018 - 03/2012
3	Chemical and Drug Induced Liver Injury 01/2023 - 11/2015
3	Body Weight (Weight, Body) 07/2021 - 11/2003
3	Cystic Kidney Diseases (Cystic Kidney Disease) 03/2020 - 01/2008
3	Hepatomegaly 11/2014 - 07/2009
2	Nephrocalcinosis 03/2022 - 07/2021
2	Hypercalciuria 03/2022 - 07/2021
2	Hyperglycemia 01/2020 - 08/2012
2	Hypertrophy 01/2019 - 01/2015
2	Kidney Calculi (Kidney Stone) 02/2017 - 01/2010
2	Albuminuria 11/2016 - 10/2011
2	Intracranial Aneurysm (Cerebral Aneurysm) 01/2016 - 01/2001

Drug/Important Bio-Agent (IBA)

41	Tolvaptan FDA Link 04/2024 - 04/2005
28	Proteins (Proteins, Gene)FDA Link 06/2023 - 01/2001
21	CreatinineIBA 06/2021 - 08/2000
20	Vasopressins (Vasopressin)IBA 01/2023 - 01/2008
20	TEMPOIBA 01/2023 - 05/2011
19	Biomarkers (Surrogate Marker)IBA 10/2023 - 08/2000
17	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 10/2021 - 01/2004
14	1-dodecylpyridoxal (PLD)IBA 01/2020 - 07/2009
12	CalciumIBA 10/2021 - 01/2006
9	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2020 - 03/2007
7	Iothalamic Acid (Iotalamic Acid)FDA Link 12/2018 - 08/2000
7	Arginine Vasopressin (Argipressin)IBA 01/2017 - 01/2008
6	TRPP Cation ChannelsIBA 05/2024 - 09/2003
6	Adenosine Monophosphate (AMP)IBA 01/2023 - 06/2009
6	SodiumIBA 07/2021 - 01/2007
6	AlbuminsIBA 11/2016 - 09/2003
6	Octreotide (Sandostatin)FDA LinkGeneric 04/2016 - 03/2007
6	Antidiuretic Hormone Receptor AntagonistsIBA 04/2015 - 11/2005
5	EnzymesIBA 01/2023 - 06/2004
5	Adenosine (Adenocard)FDA LinkGeneric 01/2019 - 11/2004
4	Cyclic AMP (AMP, Cyclic)IBA 01/2020 - 04/2004
4	AngiotensinsIBA 05/2018 - 03/2012
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2015 - 10/2011
3	Epidermal Growth Factor (EGF)IBA 06/2021 - 11/2003
3	BilirubinIBA 12/2020 - 01/2003
3	pasireotideIBA 01/2020 - 07/2013
3	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2020 - 01/2016
3	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2020 - 03/2007
3	polycystic kidney disease 1 proteinIBA 11/2019 - 02/2009
3	Sirolimus (Rapamycin)FDA Link 12/2018 - 03/2008
3	Transaminases (Aminotransferases)IBA 11/2017 - 11/2015
3	Angiotensin Receptor AntagonistsIBA 01/2015 - 10/2011
3	mozavaptanIBA 07/2008 - 04/2005
2	ceramide glucosyltransferaseIBA 01/2023 - 10/2022
2	venglustatIBA 01/2023 - 10/2022
2	Vitamin D FDA LinkGeneric 03/2022 - 07/2021
2	Vitamin D3 24-HydroxylaseIBA 03/2022 - 07/2021
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022 - 01/2020
2	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2022 - 01/2020
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022 - 11/2019
2	lixivaptanIBA 10/2021 - 01/2019
2	Calcium-Sensing ReceptorsIBA 10/2021 - 02/2009
2	N- (2- chlorophenylpropyl)- 1- (3- methoxyphenyl)ethylamineIBA 10/2021 - 02/2009
2	Antihypertensive Agents (Antihypertensives)IBA 07/2021 - 04/2011
2	Pioglitazone (Actos)FDA Link 07/2021 - 01/2010
2	Fibroblast Growth Factor-23IBA 04/2021 - 12/2019
2	SaltsIBA 11/2020 - 10/2020
2	Dietary SodiumIBA 11/2020 - 01/2017
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 03/2020 - 01/2003
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2020 - 01/2020
2	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2020 - 11/2004
2	Cyclic NucleotidesIBA 01/2020 - 01/2010
2	polycystic kidney disease 2 proteinIBA 11/2019 - 02/2009
2	ReninIBA 05/2018 - 01/2017
2	adenylyl cyclase 6IBA 01/2017 - 01/2015
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 01/2016
2	lanreotide (Somatuline)FDA Link 04/2016 - 03/2014
2	Alkaline PhosphataseIBA 04/2016 - 01/2003
2	diethylstilbestrol monophosphate (PDES)IBA 01/2016 - 01/2010
2	RNA (Ribonucleic Acid)IBA 01/2016 - 10/2014
2	4-nitrophenyl-alpha-glucosidaseIBA 01/2016 - 06/2004
2	Lisinopril (Prinivil)FDA LinkGeneric 12/2014 - 12/2014
2	Telmisartan (Micardis)FDA Link 12/2014 - 12/2014

Therapy/Procedure

28	Therapeutics 01/2023 - 12/2003
5	Kidney Transplantation 06/2023 - 08/2012
4	Transplantation 06/2023 - 08/2012
3	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2020 - 01/2015
2	Nephrectomy 01/2021 - 11/2015
2	Treatment Delay 01/2018 - 01/2017
2	Liver Transplantation 01/2016 - 07/2009
2	Hepatectomy 01/2016 - 07/2009